Acomo (ACOMO) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
23 Dec, 2025Executive summary
Achieved record full-year 2024 results with adjusted EBITDA of €109 million, up 18%, and sales up 8% to €1.4 billion, led by strong H2 recovery and segment expansion despite H1 cocoa market volatility.
All segments except edible seeds delivered double-digit sales growth in Q4; spices and nuts reached all-time high sales and profits.
Successfully integrated Delinuts Nordics acquisition, expanding the spices and nuts segment; key management positions filled and board completed.
Adjusted EPS increased 32% to €2.00; proposed full-year dividend of €1.25 per share, 82% payout ratio.
Achieved 30% reduction in Scope 1 & 2 GHG emissions since 2022 baseline.
Financial highlights
Full year sales increased by 8% to €1.36 billion, driven by spices and nuts, organic ingredients, and tea.
Adjusted EBITDA rose 18% to €109 million, returning to 2022 historic highs; adjusted EPS up 32% to €2.00.
Gross profit up 11% to €197.3 million; gross margin improved by 0.5 percentage points to 14.5%.
Net profit increased 14% to €45.1 million; reported EPS up 14% to €1.53.
Cash flow (excluding working capital) improved 15% to €106.8 million; solvency ratio at 51%, net debt/EBITDA at 2.3.
Outlook and guidance
2025 results expected to be more balanced between H1 and H2, as 2024 H2 included offset of H1 cocoa losses.
Edible seeds segment expected to return to growth as market headwinds subside and new opportunities are pursued.
Tradin Organic margins anticipated to remain at historic levels under normal market conditions.
Well-positioned for sustainable growth with a diversified plant-based portfolio and strong risk management.
No specific market forecasts due to the nature of activities and market volatility.
Latest events from Acomo
- Record results driven by strong segment growth, with sustainability and normalization ahead.ACOMO
H2 20256 Mar 2026 - EBITDA fell 9% as cocoa volatility offset record Spices & Nuts growth; dividend held at €0.40.ACOMO
H1 20243 Feb 2026 - Targets €2B sales and 9% EBITDA margin via plant-based growth, M&A, and financial discipline.ACOMO
CMD 202529 Nov 2025 - Record H1 2025 sales and profit growth, driven by Spices & Nuts and Organic Ingredients.ACOMO
H1 202516 Nov 2025 - Q3 sales up 6% to €357.3M, led by Spices, Nuts, and Organic Ingredients; US remains challenging.ACOMO
Q3 2025 TU23 Oct 2025 - Q3 revenue up 14% year-over-year, led by Spices and Nuts and Organic Ingredients growth.ACOMO
Q3 2024 TU13 Jun 2025